SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001214659-17-003231
Filing Date
2017-05-11
Accepted
2017-05-11 16:19:27
Documents
51
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 k5517010q.htm 10-Q 516284
2 EXHIBIT 31.1 ex31_1.htm EX-31.1 8461
3 EXHIBIT 31.2 ex31_2.htm EX-31.2 8530
4 EXHIBIT 32.1 ex32_1.htm EX-32.1 6382
5 EXHIBIT 32.2 ex32_2.htm EX-32.2 6485
  Complete submission text file 0001214659-17-003231.txt   3030792

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT kbio-20170331.xml EX-101.INS 526548
7 XBRL TAXONOMY EXTENSION SCHEMA kbio-20170331.xsd EX-101.SCH 38382
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE kbio-20170331_cal.xml EX-101.CAL 39974
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE kbio-20170331_def.xml EX-101.DEF 148424
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE kbio-20170331_lab.xml EX-101.LAB 285852
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kbio-20170331_pre.xml EX-101.PRE 206632
Mailing Address 1000 MARINA BOULEVARD SUITE 250 BRISBANE CA 94005-1878
Business Address 1000 MARINA BOULEVARD SUITE 250 BRISBANE CA 94005-1878 650.243.3100
KALOBIOS PHARMACEUTICALS INC (Filer) CIK: 0001293310 (see all company filings)

IRS No.: 770557236 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35798 | Film No.: 17834526
SIC: 2834 Pharmaceutical Preparations